CN107043353A - A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof - Google Patents

A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof Download PDF

Info

Publication number
CN107043353A
CN107043353A CN201611006995.8A CN201611006995A CN107043353A CN 107043353 A CN107043353 A CN 107043353A CN 201611006995 A CN201611006995 A CN 201611006995A CN 107043353 A CN107043353 A CN 107043353A
Authority
CN
China
Prior art keywords
imidazoles
phenylenediamine
benzaldehyde
imdazole derivatives
mol ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611006995.8A
Other languages
Chinese (zh)
Inventor
徐婷
段洪东
卜娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Qilu University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu University of Technology filed Critical Qilu University of Technology
Priority to CN201611006995.8A priority Critical patent/CN107043353A/en
Publication of CN107043353A publication Critical patent/CN107043353A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/95Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

The present invention relates to a kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof.First using imidazole and its derivants and 4-Fluorobenzaldehyde as raw material, 4 imidazolyl benzaldehydes or imdazole derivatives benzaldehyde are prepared.It is again raw material with itself and p-phenylenediamine, by the condensation reaction of aldehyde radical and primary amine, obtains a series of Bis-Schiff Bases with conjugated structure and rigid plane.Technique synthesis cost is low, and yield is high, and easy control of reaction conditions, purifying products are simple.Novel compound of present invention has good fluorescence property, while having selectivity to metal ion, can apply to Material Field or sensor field.

Description

A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
Technical field
The present invention relates to a kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof, the compound has firm Property planar structure, shows preferable fluorescence property, while having the C=N functional groups containing lone pair electrons, has very with metal ion Strong coordination ability, with good ion selectivity.
Background technology
Imidazoles is a kind of five member ring heterocyclic compound containing two nitrogen-atoms, as a kind of important heterocyclic compound, extensively It is general to be present in natural products.Imidazoles has very high bioactivity, can be widely used in medicine, agricultural chemicals, dyestuff and In terms of developer.In addition, glyoxaline compound is as organic nitrogen-containing heterocyclic compound, also with good coordination ability, Occupy very important status in Coordinative Chemistry.
Because imidazole molecule has the big pi bond of a closure, and the sp of the non-bonding of one of nitrogen-atoms2Have one on track To lone pair electrons, therefore it has armaticity, both shows faintly acid, and can show alkalescent.It is anti-that this just determines that chemistry occurs for imidazoles The diversity that (should be particularly substitution reaction), that is, generate the diversity of derivative, also determines that glyoxaline compound has such as Ligand complex, the premium properties such as electronics, the transitivity of proton, has further determined this kind of compound and has been with a wide range of applications. Glyoxaline compound has conjugate acid and base performance and complex coordination performance, enjoys the good reputation of " biocatalyst " " bio-ligand ".
Schiff base compounds are as a kind of important industrial chemicals, using quite varied.Due to schiff bases have it is excellent The physical material performance such as light, electricity, magnetic, the physiologically active such as antibacterial, anticancer, the weeding of good coordination property and uniqueness so that It receives extensive concern.Many reports have been carried out in medicine, agricultural chemicals, field of fine chemical on imidazolium compounds at present Lead, but the synthesis to imidazoles Bis-Schiff Bases is not reported at present.
The content of the invention
The purpose of the present invention is that there is provided the double seats of the new imidazoles benzaldehyde contracting p-phenylenediamine of a class in view of the shortcomings of the prior art Husband's alkali, the schiff bases has a good fluorescence property and ion selectivity energy, and the technique has that easy to operate, cost is low, bar The advantages of part is easily controlled, yield is high.
It is a further object of the present invention to provide the preparation method of described imidazoles benzaldehyde-p-phenylenediamine bi-schiff base.
It is a further object of the present invention to provide the application of described imidazoles benzaldehyde-p-phenylenediamine bi-schiff base.
In order to realize such purpose, technical scheme is as follows:
A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base, its structural formula is as follows:
R1For methoxyl group, hydrogen, R2For hydrogen, fluorine, chlorine, R3For hydrogen, carboxyl, nitro, hydroxyl, cyano group.
It is preferred that R1For methoxyl group, R2For chlorine, R3For nitro;
Wherein methoxyl group is outstanding electron-donating group, and chlorine atom has very strong electronegativity, and nitro has good suction Electronic action;
The compound is mainly used in Material Field or sensor field;
A kind of preparation method of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base, its preparation method is as follows:
1) imidazoles or imdazole derivatives are weighed and 4-Fluorobenzaldehyde is dissolved in solvent;
The mol ratio of described imidazoles or imdazole derivatives and 4-Fluorobenzaldehyde is 1:1~3:1;Described imidazoles or imidazoles The mol ratio of derivative and solvent is 1:15~1:90;Described imdazole derivatives are 5- nitroimidazoles, 2- methoxyl groups imidazoles, 4- Chloro- 5- nitroimidazoles;Described solvent is N,N-dimethylformamide, dimethyl sulfoxide (DMSO), ethanol;
It is preferred that imidazoles or imdazole derivatives and 4-Fluorobenzaldehyde mol ratio be 1.5:1;
2) weigh potassium carbonate and be added to step 1) described in solution, the mol ratio of imidazoles or imdazole derivatives and potassium carbonate is 1:1~1:4, constant temperature stirs 10~20h at 50~120 DEG C, is cooled to after room temperature, pours into 100mL frozen water, there is yellow solid Separate out, suction filtration, with ethyl alcohol recrystallization, obtain sterling, vacuum drying produces 4- imidazolyl benzaldehydes or imdazole derivatives benzaldehyde;
3) step 2 is weighed) 4- imidazolyl benzaldehydes or imdazole derivatives benzaldehyde and p-phenylenediamine be dissolved in solvent;
Described 4- imidazolyl benzaldehydes or the mol ratio of imdazole derivatives benzaldehyde and p-phenylenediamine are 2:1~5:1;
It is preferred that 4- imidazolyl benzaldehydes or imdazole derivatives and p-phenylenediamine mol ratio be 2:1;
Described 4- imidazolyl benzaldehydes or the mol ratio of imdazole derivatives benzaldehyde and solvent are 1:5~1:90;
Described solvent is N,N-dimethylformamide, dimethyl sulfoxide (DMSO), ethanol;
4) weigh hydrochloric acid and be added to step 3) described in mixed solution in, 4- imidazolyl benzaldehydes or imdazole derivatives benzene first The mol ratio of aldehyde and hydrochloric acid is 1:1~1:5,1~12h of isothermal reaction at 25~90 DEG C, vacuum distillation remove solvent, obtain Huang Color pulverulent solids, are purified with ethanol, methanol or re-crystallizing in ethyl acetate, and vacuum drying produces final products;
Solvent used in described recrystallization is ethanol, methanol or ethyl acetate.
The present invention reacts imidazole and its derivants and 4-Fluorobenzaldehyde, is prepared into 4- imidazolyl benzaldehydes or imidazole derivatives Thing benzaldehyde, a series of imidazoles benzaldehyde-p-phenylenediamine bi-schiff bases based on imidazoles are reacted to obtain by itself and p-phenylenediamine, warp Test, the compound has good fluorescence property and ion selectivity (result is shown in accompanying drawing 5-10).
Novel compound of present invention can also can be used for as probe application in ion detection field as fluorescent material Material Field.
Brief description of the drawings:
(1) Fig. 1,2,3,4 are the hydrogen nuclear magnetic resonance spectrogram of compound 1,2,3 and 4 respectively.
(2) Fig. 5,6 are the uv absorption spectra and fluorescence spectra of compound respectively.
(3) Fig. 7,8,9,10 are fluorogram of the compound to metalloform-selective respectively.
Embodiment:
In order to be better understood from technical scheme, it is described in further detail below by way of specific embodiment.
Embodiment 1
Imidazoles 0.680g (10mmol) is weighed, 4-Fluorobenzaldehyde 1.240g (10mmol) and Anhydrous potassium carbonate 1.380g is weighed (10mmol), is dissolved in 25mL DMF, is added to four mouthfuls of burnings of the 50mL equipped with thermometer, agitating device In bottle.Isothermal reaction 20h, is cooled to after room temperature at 60 DEG C, pours into 100mL frozen water, there is yellow solid precipitation, and suction filtration uses second Alcohol is recrystallized, and in being dried in vacuo 8h at 50 DEG C, produces 4- imidazolyl benzaldehydes.
4- imidazolyl benzaldehydes 0.172g (1mmol) is weighed, p-phenylenediamine 0.054g (0.500mmol) is weighed, is dissolved in 5mL DMF in, in the single-necked flask for being added to the 10mL equipped with thermometer, agitating device.State then up mixed Close and constant temperature stirring reaction 12h at hydrochloric acid 0.073g (2mmol), 25 DEG C is added in liquid, vacuum distillation removes solvent, obtains yellow powder Last shape solid, with ethyl alcohol recrystallization, 50 DEG C of vacuum drying 6h produce final purpose product:(the imidazoles benzaldehyde contracting pair of compound 1 Phenylenediamine Bis-Schiff Bases).Yield:90%.
Elementary analysis:C26H20N6:%C:75.89(75.00);%H:4.83(4.81);%N:19.28 (20.19) (brackets Interior is measured value).
The nmr analysis of compound 1 (nuclear magnetic spectrogram is shown in accompanying drawing 1):
Table 1 is analyzed to obtain by structural formula and hydrogen nuclear magnetic resonance spectrogram to compound 1.The compound has 10 kinds of hydrogen, its In the signal peak that occurs near 7.96-7.76ppm be proton 1,2,10 signal peak, its peak area is 3.09;In 8.75ppm The signal peak that annex occurs is the signal peak of proton 3, and its peak area is 1.00;The signal peak occurred near 7.40ppm is matter The signal peak of son 4,6, its peak area is 2.00;The signal peak occurred in 8.08ppm annexes is the signal peak of proton 5,7, its peak Area is 2.04;The signal peak occurred near 8.41ppm is the signal peak of proton 8, and its peak area is 0.99;In 7.16ppm The signal peak nearby occurred is the signal peak of proton 9, and its peak area is 1.01.It can thus be seen that the nuclear magnetic resonance of compound 1 Hydrogen spectrogram has met the structure of compound 1, i.e. imidazoles benzaldehyde-p-phenylenediamine bi-schiff base well.
The compound 1 of table 11HNMR chemical shift and peak ownership
s:It is unimodal;d:Doublet;m:Multiplet
Embodiment 2
5- nitroimidazoles 2.260g (20mmol) is weighed, 4-Fluorobenzaldehyde 1.860g (15mmol) and Anhydrous potassium carbonate is weighed 2.760g (20mmol), be dissolved in 30mL DMF, is added to equipped with thermometer, the 50mL of agitating device In four-hole boiling flask.Isothermal reaction 16h, is cooled to after room temperature at 80 DEG C, pours into 100mL frozen water, has yellow solid precipitation, takes out Filter, with ethyl alcohol recrystallization, in being dried in vacuo 10h at 50 DEG C, produces 4- (5- nitro -1- imidazole radicals) benzaldehyde.
4- (5- nitro -1- imidazole radicals) benzaldehyde 0.217g (1mmol) is weighed, p-phenylenediamine 0.027g is weighed (0.250mmol), is dissolved in 4mL DMF, is added to the single port of the 10mL equipped with thermometer, agitating device In flask.State then up and constant temperature stirring reaction 10h at hydrochloric acid 0.107g (2.932mmol), 50 DEG C is added in mixed liquor, decompression Solvent is distilled off, yellow powdery solid is obtained, with ethyl alcohol recrystallization, 60 DEG C of vacuum drying 6h produce final purpose product: Compound 2 (5- nitroimidazoles benzaldehyde-p-phenylenediamine bi-schiff base).Yield:82%.
Elementary analysis:C26H18N8O4:%C:62.08(61.66);%H:3.57(3.49);%N:21.68(22.13);% O:12.67 (12.65) (being measured value in bracket).
The nmr analysis of compound 2 (nuclear magnetic spectrogram is shown in accompanying drawing 2):
Table 2 is analyzed to obtain by structural formula and hydrogen nuclear magnetic resonance spectrogram to compound 2.The compound has 9 kinds of hydrogen, wherein The signal peak occurred near 7.75ppm is the signal peak of proton 1,2, and its peak area is 2.00;Occur in 8.88ppm annexes Signal peak is the signal peak of proton 3, and its peak area is 1.00;The signal peak occurred near 7.40ppm is the signal of proton 4,6 Peak, its peak area is 2.04;The signal peak occurred in 8.08ppm annexes is the signal peak of proton 5,7, and its peak area is 2.00; The signal peak occurred near 8.41ppm is the signal peak of proton 8, and its peak area is 1.01;The letter occurred near 7.21ppm Number peak is the signal peak of proton 9, and its peak area is 1.01.It can thus be seen that the hydrogen nuclear magnetic resonance spectrogram of compound 2 is good The structure of compound 2, i.e. 5- nitroimidazoles benzaldehyde-p-phenylenediamine bi-schiff base are met.
The compound 2 of table 21HNMR chemical shift and peak ownership
s:It is unimodal;d:Doublet;m:Multiplet
Embodiment 3
2- methoxyl group imidazoles 2.940g (30mmol) are weighed, 4-Fluorobenzaldehyde 1.860g (15mmol) and Carbon Dioxide is weighed Potassium 4.140g (30mmol), be dissolved in 40mL DMF, is added to equipped with thermometer, agitating device In 100mL four-hole boiling flask.Isothermal reaction 14h, is cooled to after room temperature at 90 DEG C, pours into 100mL frozen water, there is yellow solid analysis Go out, suction filtration, with ethyl alcohol recrystallization, in being dried in vacuo 8h at 60 DEG C, produce 4- (2- methoxyl group -1- imidazole radicals) benzaldehyde.
4- (2- methoxyl group -1- imidazole radicals) benzaldehyde 0.606 (3mmol) is weighed, p-phenylenediamine 0.130g is weighed (1.250mmol), is dissolved in 4mL DMF, is added to the single port of the 10mL equipped with thermometer, agitating device In flask.State then up and constant temperature stirring reaction 6h at hydrochloric acid 0.178g (4.877mmol), 60 DEG C is added in mixed liquor, decompression Solvent is distilled off, yellow powdery solid is obtained, with ethyl alcohol recrystallization, 50 DEG C of vacuum drying 6h produce final purpose product: Compound 3 (2- methoxyl group imidazoles benzaldehyde-p-phenylenediamine bi-schiff base).Yield:84%.
Elementary analysis:C28H26N6O2:%C:71.08(70.29);%H:4.93(5.44);%N:18.28(17.57);% O:5.71 (6.69) (being measured value in bracket).
The nmr analysis of compound 3 (nuclear magnetic spectrogram is shown in accompanying drawing 3):
Table 3 is analyzed to obtain by structural formula and hydrogen nuclear magnetic resonance spectrogram to compound 3.The compound has 10 kinds of hydrogen, its In the signal peak that occurs near 6.65ppm be proton 1,2 signal peak, its peak area is 1.99;Occur in 8.14ppm annexes Signal peak be proton 3 signal peak, its peak area be 1.00;The signal peak occurred near 7.43-7.48ppm is proton 4, 6,9 signal peak, its peak area is 3.01;The signal peak occurred in 8.01ppm annexes is the signal peak of proton 5,7, Qi Feng faces Product is 2.00;The signal peak occurred near 7.27ppm is the signal peak of proton 8, and its peak area is 1.00;It is attached in 3.85ppm The signal peak closely occurred is the signal peak of proton 10, and its peak area is 2.99.It can thus be seen that the nuclear magnetic resonance of compound 3 Hydrogen spectrogram has met the structure of compound 3, i.e. 2- methoxyl groups imidazoles benzaldehyde-p-phenylenediamine bi-schiff base well.
The compound 3 of table 31HNMR chemical shift and peak ownership
s:It is unimodal;d:Doublet;m:Multiplet
Embodiment 4
The chloro- 5- nitroimidazoles 2.970g (20mmol) of 4- are weighed, 4-Fluorobenzaldehyde 0.992g (8mmol) and anhydrous carbon is weighed Sour potassium 9.960g (70mmol), be dissolved in 35mL DMF, is added to equipped with thermometer, agitating device In 100mL four-hole boiling flask.Isothermal reaction 12h, is cooled to after room temperature at 100 DEG C, pours into 100mL frozen water, there is yellow solid Separate out, suction filtration, with ethyl alcohol recrystallization, in being dried in vacuo 8h at 50 DEG C, produces 4- (the chloro- 5- nitros -1- imidazole radicals of 4-) benzaldehyde.
4- (the chloro- 5- nitros -1- imidazole radicals of 4-) benzaldehyde 0.758g (3mmol) is weighed, p-phenylenediamine 0.161g is weighed (1.505mmol), is dissolved in 5mL DMF, is added to the single port of the 10mL equipped with thermometer, agitating device In flask.State then up and constant temperature stirring reaction 5h, vacuum distillation at hydrochloric acid 0.365g (10mmol), 70 DEG C are added in mixed liquor Solvent is removed, yellow powdery solid is obtained, with ethyl alcohol recrystallization, 50 DEG C of vacuum drying 6h produce final purpose product:Chemical combination Thing 4 (the chloro- 5- nitroimidazoles benzaldehyde-p-phenylenediamine bi-schiff bases of 4-).Yield:88%.
Elementary analysis:C26H16N8O4Cl2:%C:53.08(54.07);%H:2.57(2.78);%N:20.68 (19.41);%O:10.67(11.09);%Cl:13.00 (12.65) (being measured value in bracket).
The nmr analysis of compound 4 (nuclear magnetic spectrogram is shown in accompanying drawing 4):
Table 4 is analyzed to obtain by structural formula and hydrogen nuclear magnetic resonance spectrogram to compound 4.The compound has 8 kinds of hydrogen, wherein The signal peak occurred near 7.42ppm is the signal peak of proton 1,2, and its peak area is 2.04;Occur in 9.01ppm annexes Signal peak is the signal peak of proton 3, and its peak area is 0.99;The signal peak occurred near 8.05ppm is the signal of proton 4,6 Peak, its peak area is 1.99;The signal peak occurred in 7.68ppm annexes is the signal peak of proton 5,7, and its peak area is 1.99; The signal peak occurred near 8.56ppm is the signal peak of proton 8, and its peak area is 1.00.It can thus be seen that compound 4 Hydrogen nuclear magnetic resonance spectrogram met the structure of compound 4 well, i.e. the chloro- 5- nitroimidazoles benzaldehyde contracting p-phenylenediamine of 4- is double Schiff bases.
The compound 4 of table 41HNMR chemical shift and peak ownership
s:It is unimodal;d:Doublet;m:Multiplet
Experimental example
1st, compound fluorescence property is tested
The compound 1,2,3,4 for purification process of learning from else's experience, is dissolved using DMF, diluted, be configured to 1.0 ×10-5Mol/L sample solution.Using the uv absorption spectra of ultraviolet-uisible spectrophotometer determination sample, (result is shown in attached Fig. 5), according to the uv-absorption maximum wavelength of the compound measured, F-4600 fluorescent spectrophotometer assay compounds are utilized Fluorescence exciting wavelength, and determine the fluorescence spectrum of compound (result is shown in accompanying drawing 6).
2nd, make solvent using N,N-dimethylformamide and prepare 1.0 × 10 respectively-5Mol/L compound 1,2,3,4 and gold Belong to the 1 of ion:1 mixed solution.The fluorescence spectrum of test compound and metal ion solution (result is shown in accompanying drawing 7,8,9,10).
Result of study shows:Compound has fluorescence property, while compound 1 has preferable selection to copper ion (II) Property;Compound 2 has preferable selectivity for cadmium ion (II);Compound 3 has preferable selection for zinc ion (II) Property;Compound 4 (II) has preferable selectivity for cadmium ion.

Claims (4)

1. a kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base, it is characterised in that:Its structural formula is as follows:
R1For methoxyl group, hydrogen, R2For hydrogen, chlorine, R3For hydrogen, nitro, cyano group.
The preparation method of described imidazoles benzaldehyde contracting phenylenediamine Bis-Schiff Bases, its preparation method is as follows:
1) imidazoles or imdazole derivatives are weighed and 4-Fluorobenzaldehyde is dissolved in solvent;
The mol ratio of described imidazoles or imdazole derivatives and 4-Fluorobenzaldehyde is 1:1~3:1;Described imidazoles or imidazole derivatives The mol ratio of thing and solvent is 1:15~1:90;Described imdazole derivatives are 5- nitroimidazoles, 2- methoxyl groups imidazoles, 4- chloro- 5- nitroimidazoles;Described solvent is N,N-dimethylformamide, dimethyl sulfoxide (DMSO), ethanol;
2) weigh potassium carbonate and be added to step 1) described in solution, the mol ratio of imidazoles or imdazole derivatives and potassium carbonate is 1:1 ~1:4, constant temperature stirs 10~20h at 50~120 DEG C, is cooled to after room temperature, pours into 100mL frozen water, there is yellow solid analysis Go out, suction filtration, with ethyl alcohol recrystallization, obtain sterling, vacuum drying produces 4- imidazolyl benzaldehydes or imdazole derivatives benzaldehyde;
3) step 2 is weighed) 4- imidazolyl benzaldehydes or imdazole derivatives benzaldehyde and p-phenylenediamine be dissolved in solvent;
Described 4- imidazolyl benzaldehydes or the mol ratio of imdazole derivatives benzaldehyde and p-phenylenediamine are 2:1~5:1;
Described 4- imidazolyl benzaldehydes or the mol ratio of imdazole derivatives benzaldehyde and solvent are 1:5~1:90;
Described solvent is N,N-dimethylformamide, dimethyl sulfoxide (DMSO), ethanol;
4) weigh hydrochloric acid and be added to step 3) described in mixed solution in, 4- imidazolyl benzaldehydes or imdazole derivatives benzaldehyde with The mol ratio of hydrochloric acid is 1:1~1:5,1~12h of isothermal reaction at 25~90 DEG C, vacuum distillation remove solvent, obtain yellow powder Last shape solid, is purified with ethanol, methanol or re-crystallizing in ethyl acetate, and vacuum drying produces final products.
2. the application of compound as claimed in claim 1, it is characterised in that:Fluorescent material and ion detection field.
3. imidazoles benzaldehyde-p-phenylenediamine bi-schiff base as claimed in claim 1, it is characterised in that:Described imidazoles benzene first The mol ratio of the preparation method of aldehyde contracting p-phenylenediamine Bis-Schiff Bases, imidazoles or imdazole derivatives and 4-Fluorobenzaldehyde is 1.5:1.
4. imidazoles benzaldehyde-p-phenylenediamine bi-schiff base as claimed in claim 1, it is characterised in that:Described imidazoles benzene first The mol ratio of the preparation method of aldehyde contracting p-phenylenediamine Bis-Schiff Bases, 4- imidazolyl benzaldehydes or imdazole derivatives and p-phenylenediamine is 2:1。
CN201611006995.8A 2016-11-16 2016-11-16 A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof Pending CN107043353A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611006995.8A CN107043353A (en) 2016-11-16 2016-11-16 A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611006995.8A CN107043353A (en) 2016-11-16 2016-11-16 A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107043353A true CN107043353A (en) 2017-08-15

Family

ID=59543091

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611006995.8A Pending CN107043353A (en) 2016-11-16 2016-11-16 A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107043353A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107488151A (en) * 2017-08-28 2017-12-19 广东工业大学 A kind of compound for being used to detect copper ion or prepare preventing and treating Alzheimer disease drug and preparation method thereof and product
CN112390805A (en) * 2020-11-27 2021-02-23 齐鲁工业大学 Benzimidazole benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107488151A (en) * 2017-08-28 2017-12-19 广东工业大学 A kind of compound for being used to detect copper ion or prepare preventing and treating Alzheimer disease drug and preparation method thereof and product
CN107488151B (en) * 2017-08-28 2019-10-29 广东工业大学 It is a kind of for detecting the compound and preparation method thereof and product of copper ion or preparation prevention and treatment Alzheimer disease drug
CN112390805A (en) * 2020-11-27 2021-02-23 齐鲁工业大学 Benzimidazole benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof

Similar Documents

Publication Publication Date Title
Liu et al. Selective synthesis of osmanaphthalene and osmanaphthalyne by intramolecular CH activation
Wu et al. Dansyl-based fluorescent chemosensors for selective responses of Cr (III)
EP1406905A4 (en) Water- and organic-soluble cucurbituril derivatives, their preparation methods, their separation methods and uses
CN104130192B (en) Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof
Yang et al. Enantioselective fluorescent recognition of mandelic acid by unsymmetrical salalen and salan sensors
Yong et al. 2-Thiohydantoin containing OH and NH recognition subunits: a fluoride ion selective colorimetric sensor
Zhang et al. Four coordination polymers constructed by a novel octacarboxylate functionalized calix [4] arene ligand: syntheses, structures, and photoluminescence property
CN112062756A (en) Mannhouse donor-acceptor adduct of furan and 3-pyridine ethylamine activated by Merlox acid and synthetic method thereof
CN107043353A (en) A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
Selvakumar et al. Single stranded helical supramolecular architecture with a left handed helical water chain in ternary copper (II) tryptophan/diamine complexes
Wang et al. Altering synthetic fragments to tune the AIE properties and self-assemble grid-like structures of TPE-based oxacalixarenes
CN109503604A (en) Benzimidazole benzimidazole derivative and its synthetic method
CN113214144A (en) Metal organic framework material based on dipole organic ligand, synthetic method and application thereof
Kundu et al. Paramagnetic ruthenium-biimidazole derivatives [(acac) 2RuIII (LHn)] m, n/m= 2/+, 1/0, 0/−. Synthesis, structures, solution properties and anion receptor features in solution state
Wang et al. Synthesis, characterization and ethylene oligomerization of nickel complexes bearing N-(2-(1 H-benzo [d] imidazol-2-yl) quinolin-8-yl) benzamide derivatives
Teramae et al. Dinuclear copper–dioxygen intermediates supported by polyamine ligands
Yao et al. Quinoline-functionalized norbornene for fluorescence recognition of metal ions
CN104119286B (en) A kind of triazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
Navarro et al. Isomeric DTPA-amide macrocycles of p-xylenediamine and their complexation with Gd3+
CN107129464B (en) A kind of 2,3,5,6- tetra- replaces the preparation method of symmetrical pyridine
Takahashi et al. Luminescent europium (III) complexes of tripodal heptadentate N7 ligands containing three imidazole groups
Powell et al. Facile syntheses of thiophene-substituted 1, 4-diazabutadiene (α-diimine) ligands and their conversion to phosphenium triiodide salts
Rahman et al. 42 members new hydroquinone bridged supramolecular macrocycle and its tetra-nuclear mixed ligands Pt (II) complex: A synthetic, structural and spectroscopic investigation
JP2022069882A (en) Novel compound and anion receptor
CN106967086B (en) It is a kind of with the quino sulphur pyran derivate and its synthetic method of antibacterial activity and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170815